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INTRODUCTION:  A carcinoid  tumor  occurring  in the  endometrium  has been  documented  in the  literature,
but  there  is  no  report  in regard  to  carcinoid  tumor  metastasis  to endometrium.
PRESENTATION OF CASE:  We  report  a  case  of  a malignant  carcinoid  metastasis  to  an  endometrial  polyp.
Patient  underwent  hysteroscopy,  and  polypectomy.  The  pathology  demonstrated  an  endometrial  polyp
containing  a  4  mm  x 5  mm  nodule  of  metastatic  carcinoid  tumor,  consistent  with  metastasis  from  patient’s
known  pulmonary  carcinoid.  The  tumor  was  morphologically  similar  to the  tumors  of  the right  lung,  with
similar  immune-proﬁle.
DISCUSSION:  This  patient  presented  with  a suspicious  pelvic  ultrasound.  Due  to  her  age,  the ﬁrst  priority
was  to exclude  uterine  cancer.  The  endometrial  polyp,  which  was found,  had  a small  focus  of metastatic
carcinoid  tumor.  To  the  best  of  our  knowledge,  this  ﬁnding  has not  been  previously  recorded  in the
literature.  Our  patient  also  had  a  history  of  metastatic  carcinoid  tumor  to breast.  This  ﬁnding  is also  very
uncommon.
CONCLUSION:  This  is  the  ﬁrst  case  in the  literature  described  a malignant  carcinoid  metastasis  to an
endometrial  polyp.
gical © 2012 Sur
. Introduction
We  report a case of a malignant carcinoid metastasis to an
ndometrial polyp which to the best of our knowledge has not
een previously recorded in the literature. Carcinoid tumors were
rst described over 100 years ago by Lubarsch, who  found mul-
iple tumors in the distal ileum of two patients at autopsy.1
berndorfer used the term karzinoide in 1907 to describe sim-
lar tumors that appeared to behave in a more indolent fashion
han typical adenocarcinomas.2 A carcinoid tumor occurring in the
ndometrium has been documented in the literature,3,4 but there is
o report in regard to carcinoid tumor metastasis to endometrium.
his patient also had mammary manifestation of metastatic carci-
oid tumor, which is extremely rare.5
. Case reportThe  patient gave her informed consent in order for her case to be
resented. A 70-year-old white post menopausal woman  with his-
ory of carcinoid tumor of the lung was referred to the gynecologic
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oncology service after pelvic transvaginal sonography revealed an
abnormal thickening of the endometrial echo complex measuring
up to 1.4 cm at the uterine fundus. The ﬁnding was suggestive
of an interval enlargement of a known polyp. The patient had
experienced no postmenopausal uterine bleeding. Conﬁrmatory
sonohystogram revealed a cyctic polyp at the fundus of the uterus
measuring 15 mm × 13 mm.  Patient underwent hysteroscopy and
polypectomy without complication. The ﬁnal pathology revealed
the endometrial polyp to encompass a nodule of metastatic carci-
noid.
The history of present illness began in October 1993 when
a chest X-ray was  notable for a right lung nodule. The patient
underwent right thoracotomy with right lower lobectomy. Three
tumors were found. All were pathological carcinoid. In 2005 (12
years later), she underwent left thoracotomy with resection of
the left lower lobe. A 2.2 cm carcinoid tumor and multiple addi-
tional carcinoid tumorlets measuring up to 0.4 cm were removed.
In 2008 the patient underwent an ultrasound guided core biopsy of
a left breast lesion. Pathology again revealed metastastic carcinoid
with similar histologically to the patient’s initial lung carcinoid.
The patient was  initiated on Octreotide therapy. Which she cur-
rently receives on a monthly basis. Additional medical history
is notable for severe asthma, gastroesophageal reﬂux disease,
Open access under CC BY-NC-ND license.recurrent bronchiectasis, recurrent bronchitis, and recurrent pneu-
monia. The patient’s family history is signiﬁcant for colorectal
cancer in her father, and no breast or gynecologic cancer in her
family.
 BY-NC-ND license.
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ung  tumor H&E 100×; (C) endometrium chromogranin 400×; and (D) primary lun
. Surgical pathology
Pathology demonstrated an endometrial polyp containing
 4 mm × 5 mm nodule of metastatic carcinoid tumor, consis-
ent with metastasis from patient’s known pulmonary carcinoid.
mmunohistochemical studies show that the specimen was
trongly positive for chromogranin and synaptophysin. It was
egative for Cytokeratin AE1/AE3 and equivocal for thyroid tran-
cription factor 1 (TTF1). The tumor was morphologically similar to
he tumors of the right lung in 1993, with similar immune-proﬁle
Fig. 1). The specimens from the carcinoid tumor from the left lung
btained by ﬁne needle biopsy in 2005, and the right breast in 2008
ere similar morphologically to that in the endometrial polyp. Both
ere positive for chromogranin and synaptophysin, but they were
lso positive for Cytokeratin AE1/AE3 and TTF1.
. Discussion
This patient presented with a suspicious pelvic ultrasound.
ue to her age, the ﬁrst priority was to exclude uterine cancer.
he patient underwent hysteroscopic resection and endometrial
ampling. The endometrial polyp had a small focus of metastatic
arcinoid tumor. To the best of our knowledge, this ﬁnding has not
een previously recorded in the literature. Our patient also had a
istory of metastatic carcinoid tumor to breast. This ﬁnding is also
ery uncommon. A review of the literature by Fishman et al. dis-
losed only 13 reported cases of carcinoid tumor metastatic to the
reast.5
Carcinoid (typical carcinoid and atypical carcinoid) tumor is a
ell differentiated neoplasm and part of the neuroendocrine tumor
amily; well and poorly differentiated neuroendocrine tumors are
rouped together only because of generic neuroendocrine marker
xpression such as synaptophysin and chromogranin. These tumors
re thought to arise from the neuroendocrine tissue of the aerodi-
estive, gynecologic, and genitourinary tracts.6s exhibit strong chromogranin positivity: (A) endometrium H&E 100×; (B) primary
or chromogranin 400×.
Carcinoid tumor can originate from fore-gut, mid-gut and hind-
gut. Fore-gut carcinoid tumors most commonly originate in the
lungs, bronchi, or stomach; mid-gut carcinoid tumors most com-
monly originate in the small intestine, appendix, and proximal large
bowel; and hind-gut carcinoid tumors originate in the distal colon
and rectum. The overall incidence of carcinoid tumors in the United
States is estimated to be 5–6 cases per 100,000 people.7 Yao et al.
noted a signiﬁcant increase in reported annual age-adjusted inci-
dence from 1973 (1.09/100,000) to 2004 (5.25/100,000).7,8 Because
many carcinoid tumors are indolent, their true incidence may  be
higher. A Swedish study reviewed both surgical specimens and
autopsies in a single geographic location and reported the inci-
dence to be 8.4 cases per 100,000 people.9 An analysis of 35,825
cases by Yao et al. in the United States showed the locations of the
primary tumors varied signiﬁcantly by sex. Female patients were
more likely to have a primary tumor in the lung, stomach, appendix,
or cecum, whereas male patients were more likely to have a pri-
mary tumor in the thymus, duodenum, pancreas, jejunum/ileum,
or rectum. The primary tumor sites also varied signiﬁcantly by race.
In particular, the lung was the primary site more often among
Caucasian patients (30%) than among patients in the other racial
groups.7
Pulmonary carcinoid makes up approximately 2% of primary
lung tumors.10,11 They are thought to arise from neuroendocrine
Kulchitsky’s  cells located in the bronchial mucosa.12,13 The major-
ity of the tumors are peri-hilar in location, and patients often
present with recurrent pneumonia, cough, hemoptysis, or chest
pain.14 Lung carcinoids may  secrete various hormones, giving
rise to a carcinoid syndrome, a variant carcinoid syndrome or
rarely Cushing’s syndrome, acromegaly, or other peptide produced
endocrine syndrome.15 Well-differentiated pulmonary neuroen-
docrine tumors are usually indolent, with metastases reported in
less than 15% of cases.14,16,17 When they do occur, metastases usu-
ally can develop in mediastinal lymph nodes, liver, bone, skin, or
brain. This patient developed metastasis to her breast. It is likely
that this patient’s multiple pulmonary carcinoids associated with
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ultiple tumorlets were not metastasis but rather metaschimous
rimary carcinoid arising from a background of “Diffuse Idiopathic
ulmonary Neuroendocrine Cell Hyperplasia” (DIPNECH).18
In the gynecological Oncology literatures, it is well recognized
hat carcinoid tumors can arise within ovarian teratomas.19–21 Rare
ases have been described in the uterine cervix.22 A carcinoid tumor
f the endometrium has been described by Albores-Saavedra et al.
nd extension from such an origin into the myometrium would
ccount for the intramuscular location of this tumor; and this
umor histologically was similar to the mid-gut carcinoid4; there
s no obvious embryological link to explain this ﬁnding. Primary
arcinoid tumors of the ovary account for less than 0.1% of all
varian neoplasms.6 These tumors are typically classiﬁed as germ
ell tumors of the ovary and can be divided into four categories:
nsular, Trabecular, Mucinous and Strumal.6,23 The insular and tra-
ecular are the most common subtypes that metastasized to the
vary. Given the rarity of the disease, it is also critical to rule out
 metastatic GI primary that could metastasize to the ovary, and
ends to present as bilateral ovarian metastases.6 Microscopically,
he metastatic carcinoid is composed of tumor nodules, whereas
rimary ovarian carcinoid forms a single homogenous mass. The
resence of other teratomatous elements that are associated with
n ovarian carcinoid conﬁrms that it is of primary ovarian origin.
n our case the immune-proﬁle of carcinoid nodule of endome-
rial polyp was consistent with metastasis from patient’s known
ulmonary carcinoid.
onﬂict  of interest statement
None.
unding
None.
onsent
We  obtained written and signed consent to publish the case
eport from the patient.
uthor  contributions
Mazdak Momeni, M.D.; Howard H. Mizrachi, M.D. – manuscript
riting, editing, and picture preparation.
Valentin Kolev, M.D.; Dan Costin, M.D.; Linus Chuang, M.D.;
ichard R.P. Warner, M.D.; Herbert F. Gretz M.D. – manuscript writ-
ng and editing.
2
2PEN  ACCESS
f Surgery Case Reports 4 (2013) 91– 93 93
References
1. Lubarsch O. Ueber den primären Krebs des Ileum, nebst Bemerkungen über
das gleichzeitige Vorkommen von Krebs und Tuberkolose. Virchows Archiv
1888;111:280–317.
2. Oberndorfer S. Karzinoide Tumoren des Dünndarms. Frankfurter Zeitschrift fur
Pathologie 1907;1:425–9.
3. Chetty R, Clark SP, Bhathal PS. Carcinoid tumour of the uterine corpus. Virchows
Archiv Abteilung A Pathologische Anatomie 1993;422:93–5.
4. Albores-Saavedra J, Rodriquez-Martinez HA, Larraza-Hernandez O. Carcinoid
tumours of the cervix. Pathology Annual 1979;14:273–91.
5. Fishman A, Kim HS, Girtanner RE, Kaplan AL. Case report solitory breast metas-
tasis as ﬁrst manifestation of ovarian carcinoid tumor. Gynecolgic Oncology
1994;54:222–6.
6. Gardner  GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gyne-
cologic tract: A Society of Gynecologic Oncology (SGO) clinical document.
Gynecologic  Oncology 2011;122:190–8.
7. Yao JC, Hassan M,  Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming
JB,  Vauthey J, Rashid A, Evanset DB. One hundred years after “carcinoid”: epi-
demiology of prognostic factors for neuroendocrine tumors in 35,825 cases in
the United States. Journal of Clinical Oncology 2008;26:3063–72.
8. Godwin J. Carcinoid tumors: an analysis of 2837 cases. Cancer 1975;36:560–9.
9. Berge T, Linell F. Carcinoid tumours: frequency in a deﬁned population dur-
ing a 12-year period. Acta Pathologica et Microbiologica Scandinavica Section A,
Pathology 1976;84:322–30.
0. Harpole Jr DH, Feldman JM, Buchanan S, Young WG,  Wolfe WG.  Bronchial carci-
noid tumors: a retrospective analysis of 126 patients. Annals of Thoracic Surgery
1992;54:50–5.
1. Vadasz P, Palffy G, Egervary M,  Schaff Z. Diagnosis and treatment of bronchial
carcinoid  tumors: clinical and pathological review of 120 operated patients.
European Journal of Cardio-Thoracic Surgery 1993;7:8–11.
2.  Gould VE, Linnoila RI, Memoli VA, Warren WH.  Neuroendocrine components of
the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Labora-
tory Investigation 1983;49:519–37.
3. Paladugu RR, Benﬁeld JR, Pak HY, Ross RK, Teplitz RL. Bronchopulmonary Kul-
chitzky cell carcinomas: a new classiﬁcation scheme for typical and atypical
carcinoids.  Cancer 1985;55:1303–11.
4. Okike N, Bernatz PE, Woolner LB. Carcinoid tumors of the lung. Annals of Thoracic
Surgery 1976;22:270–7.
5. Granberg D, Oberg K. Neuroendocrine tumours. Update on Cancer Therapeutics
2006;1(1):75–84.
6. McCaughan BC, Martini N, Bains MS.  Bronchial carcinoids: review of 124 cases.
Journal of Thoracic and Cardiovascular Surgery 1985;89:8–17.
7.  Torre M, Barberis M,  Barbieri B, Bonacina E, Belloni P. Typical and atypical
bronchial  carcinoids. Respiratory Medicine 1989;83:305–8.
8. Davies SJ, Gosney JR, Hansell DM,  Wells AU, du Bois RM,  Burke MM,  Sheppard
MN,  Nicholson AG. Diffuse idiopathic pulmonary neuroendocrine cell hyperpla-
sia: an under-recognised spectrum of disease. Thorax 2007;62:248–52.
9. Robboy SJ, Norris HJ, Scully RE. Insular carcinoid primary in the ovary: a clinico-
pathologic analysis of 48 cases. Cancer 1975;36:404–18.
0. Torvik A. Carcinoid syndrome in a primary tumor of the ovary. Report of a case
with extensive peritoneal ﬁbrosis resembling Pick’s syndrome. Acta Pathologica
1959;48:81–8.
1. Robboy SJ, Scully RE. Strumal carcinoid of the ovary: an analysis of 50 cases
of a distinctive tumor composed of thyroid tissue and carcinoid. Cancer
1980;46(9):2019–34.
2.  Albores-Saavedra J, Larraza O, Poucell S, Martinez HAR. Carcinoid of uterine
cervix.  Cancer 1976;38:2328–42.
3. Talerman A. Germ cell tumor of the ovary. In: Kurman RJ, editor. Blaun-
stein’s  pathology of the female genital tract. New York: Springer-Verlag; 2002.
p. 1006–8.
